Aisa Pharma is focused on developing novel treatments for the pressing medical need of patients with Raynaud’s disease and painful conditions in which augmenting peripheral blood flow may improve disease symptoms and outcomes.

About Profervia®

Profervia® is being developed to treat primary and secondary Raynaud’s disease.

Our Team

We have decades of experience in pharmaceutical product development.

Contact Us

Keep in touch! Submit a question or subscribe to our mailing list.